Phase III trial of tarafenacin in overactive bladder syndrome.
Latest Information Update: 11 Apr 2013
At a glance
- Drugs Tarafenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Kwang Dong Pharmaceutical; SALVAT
- 11 Apr 2013 New trial record